Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1346 mTFF2-MSA (mTNX-1700) suppresses tumor growth in an Anti-PD-1 treated Pan02 syngeneic pancreatic cancer model by targeting MDSCs in C57BL/6 Mice
Compose a Response to This Article
Other responses
No responses have been published for this article.
